Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

WOK vs PAVS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PAVS Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 4–3 Matrix Metrics)

PAVS Overall Winner 6-Pillar Tally: WOK 2 – 3 PAVS (1 Tie) Matrix Metrics: WOK 3 – 4 PAVS

As of Nov 16, 2026, Paranovus Entertainment Technology Ltd. Class A (PAVS) is the stronger overall head-to-head candidate over WORK Medical Technology Group LTD Class A (WOK) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). WOK carries a Unified Composite Score of 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin), whereas PAVS carries 45.5/100 (HOLD) at $2.26 (N/M Forward P/E, -23.1% operating margin).

  • Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile PAVS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About WOK vs PAVS
WOK NASDAQ
WORK Medical Technology Group LTD Class A Ordinary Shares
Surgical & Medical Instruments & Apparatus
$1.23
+2.5% 1D
Market Cap $5.4M
TTM Revenue $11M
Forward P/E N/M
Beta / 30D Vol 38.49β · 153% Vol
Unified Composite Score
25.6 / 100 SELL
Tech 5.0 Fund 39.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 49
RSI-14: 49.1 · SMA20: $1.13 · SMA50: $1.47
PAVS NASDAQ Head-to-Head Winner
Paranovus Entertainment Technology Ltd. Class A Ordinary Shares
Services-Computer Processing & Data Preparation
$2.26
-10.32% 1D
Market Cap $2.2M
TTM Revenue $15M
Forward P/E N/M
Beta / 30D Vol 113.43β · 116% Vol
Unified Composite Score
45.5 / 100 HOLD
Tech 33.0 Fund 47.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -24.2%), weak momentum, RSI 31
RSI-14: 30.6 · SMA20: $2.87 · SMA50: $3.51

6-Pillar Scorecard Institutional Category Breakdown (WOK 2 – 3 PAVS)

Columns: Metric · WOK · PAVS
1. Valuation Multiples PAVS
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.5x 0.1x
2. Growth & Scale PAVS
Revenue Growth (YoY) +19.1% +70798.0%
Earnings Growth (YoY) -95.0% +0.0%
TTM Revenue (USD) $11M $15M
Market Cap $5.4M $2.2M
3. Profitability & Quality WOK
Gross Margin 17.0% 16.5%
Operating Margin -41.7% -23.1%
Net Profit Margin -41.9% -87.2%
Return on Equity (ROE) -19.2% -50.7%
4. Balance Sheet & Cash Flow PAVS
Cash Generation (TTM) -$3.4M EBITDA -$1.2M EBITDA
Cash Flow Margin -31.4% EBITDA Mgn -8.3% EBITDA Mgn
Net Cash / Leverage $1855.16 Book/Sh · -19.2% ROE $2350.58 Book/Sh · -50.7% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat WOK
OpEx & R&D Intensity 58.7% of Rev ($6.3M) 39.6% of Rev ($5.8M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Footwear & Accessories Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: WOK (3) vs PAVS (4)
Institutional Metric WOK PAVS Criterion Row Edge
Market Capitalization
Scale
$5.4M $2.2M Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+19.1% +70798.0% Higher Growth PAVS
Operating Margin (TTM)
Profitability
-41.7% -23.1% Higher Margin PAVS
Net Profit Margin
Profitability
-41.9% -87.2% Higher Margin WOK
Return on Equity (ROE)
Capital Efficiency
-19.2% -50.7% Higher ROE WOK
52-Week Range Position
Momentum
16% ($0–$7) 8% ($0–$27) Stronger Trend WOK
Beta / 30D Volatility
Risk Regime
38.49β · 153% Vol 113.43β · 116% Vol Lower Realized Risk PAVS
Unified Institutional Score
Composite Signal
25.6 / 100 (SELL) 45.5 / 100 (HOLD) Higher Composite PAVS
Trailing 12M Revenue (USD)
Operating Scale
$11M $15M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.0% 16.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.5x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$3.4M EBITDA ($1855.16 Book/Sh · -19.2% ROE) -$1.2M EBITDA ($2350.58 Book/Sh · -50.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon WOK +38.5 pp
WOK: +12.84% · PAVS: -25.66%
3M Horizon WOK +17.28 pp
WOK: -44.09% · PAVS: -61.37%
6M Horizon WOK +120.08 pp
WOK: +223.68% · PAVS: +103.6%
1Y Horizon PAVS +363.53 pp
WOK: -72.05% · PAVS: +291.48%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WOK vs PAVS. Trailing 12-month operating profitability (WOK -41.7% vs PAVS -23.1%) and valuation multiples (WOK N/M vs PAVS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

WOK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$11M
Gross Margin17.0%
Op. Margin-41.7%
ROE / Fwd P/E-19.2% · N/M
PAVS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$15M
Gross Margin16.5%
Op. Margin-23.1%
ROE / Fwd P/E-50.7% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
WOK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact WOK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PAVS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PAVS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
WOK Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $5.4M market capitalization and -41.7% operating margin.
OpEx & R&D Reinvestment 58.7% of Rev ($6.3M)
90D Engineering Disclosures 0 Published
PAVS Moat Profile Cyclical / Execution-Driven Positioning
Footwear & Accessories Operator
Competes within the Footwear & Accessories value chain with $2.2M market capitalization and -23.1% operating margin.
OpEx & R&D Reinvestment 39.6% of Rev ($5.8M)
90D Engineering Disclosures 0 Published

Investor FAQ WOK vs PAVS Key Questions & Quantitative Answers

As of Nov 16, 2026, Paranovus Entertainment Technology Ltd. Class A (PAVS) is the stronger overall head-to-head candidate over WORK Medical Technology Group LTD Class A (WOK) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). WOK carries a Unified Composite Score of 25.6/100 (SELL) at $1.23 (N/M Forward P/E, -41.7% operating margin), whereas PAVS carries 45.5/100 (HOLD) at $2.26 (N/M Forward P/E, -23.1% operating margin). Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile PAVS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PAVS leads the Growth & Scale pillar: WOK posts +19.1% YoY revenue growth and -95.0% YoY earnings growth on $11M TTM revenue (17.0% gross margin, -41.7% operating margin), compared with PAVS at +70798.0% YoY revenue growth and +0.0% YoY earnings growth on $15M TTM revenue (16.5% gross margin, -23.1% operating margin). On trailing 12-month operating scale, WOK generates $11M in USD-normalized revenue versus $15M for PAVS. In operating R&D and SG&A reinvestment, WOK deploys 58.7% of Rev ($6.3M) (0 90-day corporate R&D disclosures) versus 39.6% of Rev ($5.8M) (0 disclosures) for PAVS.

PAVS screens cheaper on headline valuation multiples. WOK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-31.4% EBITDA margin), whereas PAVS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-8.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WOK (-19.2% ROE) versus PAVS (-50.7% ROE) capital efficiency.

In options market volatility and institutional positioning, WOK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (38.49β · 153% Vol realized risk). By comparison, PAVS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (113.43β · 116% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

WORK Medical Technology Group LTD Class A Ordinary Shares (WOK) Research Suite

Paranovus Entertainment Technology Ltd. Class A Ordinary Shares (PAVS) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.